ENvue Medical, Inc. (FEED)
FEED is quoted over the counter, not listed on an exchange. ENvue Medical, Inc. files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.
Closes: Yahoo Finance daily closes, last bar 2026-11-16.
Profile
| Field | Value |
|---|---|
| Ticker | FEED, quoted over the counter |
| SEC CIK | 0001326706 |
| OTC Markets tier | Pink (price source, 2026-11-13) |
| SEC industry code | Orthopedic, Prosthetic & Surgical Appliances & Supplies |
| Business address | Tyler, TX |
| Incorporated in | DE |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | States substantial doubt about continuing as a going concern. "These conditions raise substantial doubt about the Company's ability to continue as a going concern for twelve months from the date of issuance of these interim condensed consolidated financial statements." | 10-Q 2026-08-17 |
| Cash and burn | $1.1M cash; operating cash flow -$2.9M a quarter. | Report 2026-06-30 |
| Shares outstanding | 923,718 (2026-08-17); 796,950 a year earlier; 1,662,330 three years earlier. 3y figure adjusted for splits (1-for-110 overall). | Cover page 2026-08-17 |
| Reverse splits, 3 years | 3; latest 1-for-12 on 2026-09-01 | Source 2026-09-01 |
| Shelf and offerings, 12 months | 2 S-3/F-3 shelf filings; 0 424B5 takedowns | Latest 2026-08-10 |
| Exchange deficiency notices, 12 months | 1 (8-K item 3.01) | 8-K 2026-07-10 |
| Auditor | Kost Forer Gabbay & Kasierer, Tel Aviv, Israel; changed auditors 1 time in 24 months | 8-K 4.01 2025-08-14 |
| Late filings, 12 months | 3 NT notices | NT 10-Q 2026-08-14 |
| Insider trades, 12 months | Bought $0, sold $151K on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q2 2026 2026-06-30 | $239K | -$4.9M | -$2.7M | $1.1M | $2.2M | $1.9M | 10-Q 2026-08-17 |
| Q1 2026 2026-03-31 | $653K | -$3.8M | -$4.3M | $2.2M | $2.2M | $2.2M | 10-Q 2026-05-18 |
| Q4 2025 2025-12-31 | $312K | -$12.9M | -$2.7M | $4.2M | $2.2M | $2.6M | 10-K 2026-04-15 |
| Q3 2025 2025-09-30 | $722K | $510K | -$2.0M | $7.0M | $2.1M | $2.7M | 10-Q 2025-11-14 |
| Q2 2025 2025-06-30 | $494K | -$4.0M | -$3.4M | $4.0M | $2.0M | $2.3M | 10-Q 2026-08-17 |
| Q1 2025 2025-03-31 | $1.0M | -$1.9M | -$1.3M | $571K | $1.3M | $2.7M | 10-Q 2026-05-18 |
| Q4 2024 2024-12-31 | $444K | -$1.4M | -$548K | $752K | $2.3M | $2.6M | 10-K 2026-04-15 |
| Q3 2024 2024-09-30 | $376K | -$998K | -$836K | $1.3M | No debt tags | $3.3M | 10-Q 2025-11-14 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | S-3 | 2026-08-10 |
| Latest annual report | 10-K | 2026-04-15 |
| Latest quarterly / interim | 10-Q | 2026-08-17 |
| Latest current report | 8-K | 2026-10-14 |
| Latest proxy | DEF 14A | 2026-07-24 |
Source: SEC EDGAR submissions feed, 551 recent filings. All filings on EDGAR.
The full dossier has every filing, quarterly and annual financials, the health record and a price chart.
Open the full dossier